Soranib contains Sorafenib 200 mg, a targeted therapy used for liver, kidney, and thyroid cancers. It works by blocking proteins that help cancer cells grow and spread.
| Generic Name | Sorafenib |
| Manufacturer | CIPLA |
| Packing | 120 Tablets |
| Prescribed For | Liver cancer, kidney cancer, and thyroid cancer |
| Expiry | December 2027 |
Sorafenat contains Sorafenib 200 mg, a targeted cancer therapy used for liver cancer, kidney cancer, and thyroid cancer. It works by blocking signals that promote tumor growth and spread.
| Generic Name | Sorafenib |
| Manufacturer | NATCO |
| Packing | 120 Tablets |
| Prescribed For | Liver cancer, kidney cancer, and thyroid cancer |
| Expiry | December 2027 |
Cabozer (Cabozantinib 40mg Tablet) is used to treat advanced kidney, liver, and thyroid cancers by blocking cancer cell growth and spread.
| Composition | Cabozantinib |
| Manufacturer | Aprazer |
| Packing | 30 Tablets |
| Prescribed For | Kidney, Liver, and Thyroid Cancers |
| Expiry | December 2027 |
Lenshil contains Lenvatinib 4mg, a targeted cancer medicine used in the treatment of thyroid cancer, kidney cancer (renal cell carcinoma), and liver cancer (hepatocellular carcinoma).
| Composition | Lenvatinib |
| Manufacturer | Shilpa Medicare Ltd |
| Packing | 10 Capsules |
| Prescribed For | Thyroid Cancer, Kidney Cancer, Liver Cancer |
| Expiry | December 2027 |
Lentris contains Lenvatinib 10mg, a targeted cancer therapy used to treat advanced stages of thyroid cancer, liver cancer (hepatocellular carcinoma), and kidney cancer (renal cell carcinoma).
| Composition | Lenvatinib |
| Manufacturer | Mylan Pharmaceuticals Pvt Ltd |
| Packing | 30 Capsules |
| Prescribed For | Thyroid Cancer, Kidney Cancer, Liver Cancer |
| Expiry | December 2027 |
Lenvakast contains Lenvatinib 10mg, a targeted therapy used in the treatment of advanced thyroid cancer, renal cell carcinoma (kidney cancer), and hepatocellular carcinoma (liver cancer).
| Composition | Lenvatinib |
| Manufacturer | Aprazer Healthcare Pvt Ltd |
| Packing | 30 Capsules |
| Prescribed For | Thyroid Cancer, Kidney Cancer, Liver Cancer |
| Expiry | December 2027 |
Lenvat contains Lenvatinib 10mg, a targeted therapy used in the treatment of thyroid cancer, kidney cancer (renal cell carcinoma), and liver cancer (hepatocellular carcinoma).
| Composition | Lenvatinib |
| Manufacturer | Natco Pharma Ltd |
| Packing | 30 Capsules |
| Prescribed For | Thyroid Cancer, Kidney Cancer, Liver Cancer |
| Expiry | December 2027 |
Lenvatol contains Lenvatinib 10mg, a targeted anti-cancer medicine used for treating certain types of advanced or metastatic cancers including thyroid cancer, renal cell carcinoma (kidney cancer), and hepatocellular carcinoma (liver cancer).
| Composition | Lenvatinib |
| Manufacturer | Cipla Ltd |
| Packing | 10 Capsules |
| Prescribed For | Thyroid Cancer, Kidney Cancer, Liver Cancer |
| Expiry | December 2027 |
Lenvenib contains Lenvatinib 4mg, a targeted cancer therapy used to treat advanced thyroid cancer, kidney cancer (renal cell carcinoma), and liver cancer (hepatocellular carcinoma).
| Composition | Lenvatinib |
| Manufacturer | Sun Pharmaceutical Industries Ltd |
| Packing | 7 Capsules in 1 Strip |
| Prescribed For | Thyroid Cancer, Kidney Cancer, Liver Cancer |
| Expiry | December 2027 |
Regonat contains Regorafenib 40 mg, a targeted chemotherapy medicine used to treat certain types of cancers, including colorectal cancer, gastrointestinal stromal tumors (GIST), and hepatocellular carcinoma (liver cancer).
| Composition | Regorafenib |
| Manufacturer | Natco Pharma Ltd |
| Packing | 28 Tablets |
| Prescribed For | Colorectal Cancer, Liver Cancer and GIST |
| Expiry | December 2027 |
Sorafekast 200mg contains Sorafenib, a targeted cancer therapy used in the treatment of advanced liver cancer (Hepatocellular Carcinoma), kidney cancer (Renal Cell Carcinoma), and certain types of thyroid cancer.
| Composition | Sorafenib (200mg) |
| Manufacturer | Aprazer Healthcare Pvt Ltd |
| Packing | 30 Tablets in 1 Bottle |
| Prescribed For | Liver Cancer, Kidney Cancer and Thyroid Cancer |
| Expiry | December 2027 |
Stivarga 40 mg Tablet contains Regorafenib, an oral targeted therapy used to treat certain types of cancers such as metastatic colorectal cancer, gastrointestinal stromal tumors (GIST), and hepatocellular carcinoma (liver cancer).
| Composition | Regorafenib |
| Manufacturer | Bayer |
| Packing | 28 Tablets in 1 Bottle |
| Prescribed For | Metastatic Colorectal Cancer, GIST, and Hepatocellular Carcinoma |
| Expiry | December 2027 |
Glenvas 10mg Capsule contains Lenvatinib, an oral targeted therapy used to treat certain types of advanced cancers, including thyroid cancer, liver cancer, kidney cancer, and endometrial cancer.
| Composition | Lenvatinib |
| Manufacturer | Glenmark Pharmaceuticals Ltd |
| Packing | 30 Capsules |
| Prescribed For | Thyroid, Liver & Kidney Cancer |
| Expiry | December 2027 |
Cazanat 60mg contains Cabozantinib, a targeted therapy used in the treatment of certain types of cancers, including advanced kidney cancer (renal cell carcinoma) and liver cancer (hepatocellular carcinoma).
| Composition | Cabozantinib |
| Manufacturer | Natco Pharma Ltd |
| Packing | 30 Tablets |
| Prescribed For | Kidney and Liver Cancer |
| Expiry | December 2027 |
